According to a recent LinkedIn post from Resilience Care, the company is emphasizing collaboration as a core theme for the first quarter of 2026. The post indicates that its oncology remote-monitoring solution is now deployed across 160 healthcare establishments in Europe, suggesting a growing footprint in the cancer care ecosystem.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post highlights that Institut Curie has joined its network as the second comprehensive cancer center in the Île-de-France region to adopt its approach for more personalized patient follow-up. Resilience Care also reports that more than 35,000 patients have benefited from remote monitoring via its platform, with 86% reportedly recommending the solution.
In addition, the LinkedIn update points to two new collaborations with Ipsen and Association ARTIC, focused on real-world research in uro-oncology and better understanding patient care pathways. For investors, these developments may signal expanding clinical validation, stronger reference customers, and deeper data assets, which could enhance Resilience Care’s positioning in digital oncology and support future commercialization and partnership opportunities.